A detailed history of Gmt Capital Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 1,908,366 shares of ANNX stock, worth $10.1 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,908,366
Previous 2,939,945 35.09%
Holding current value
$10.1 Million
Previous $14.4 Million 21.58%
% of portfolio
0.46%
Previous 0.61%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $4.63 Million - $7.43 Million
-1,031,579 Reduced 35.09%
1,908,366 $11.3 Million
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $1.27 Million - $2 Million
294,421 Added 11.13%
2,939,945 $14.4 Million
Q1 2024

May 13, 2024

SELL
$4.03 - $7.81 $1.51 Million - $2.93 Million
-374,950 Reduced 12.41%
2,645,524 $19 Million
Q4 2023

Feb 12, 2024

BUY
$1.63 - $4.63 $342,304 - $972,313
210,003 Added 7.47%
3,020,474 $13.7 Million
Q3 2023

Nov 13, 2023

BUY
$2.13 - $3.84 $736,767 - $1.33 Million
345,900 Added 14.03%
2,810,471 $6.63 Million
Q2 2023

Aug 10, 2023

BUY
$2.1 - $6.37 $2.22 Million - $6.73 Million
1,055,874 Added 74.95%
2,464,571 $8.68 Million
Q1 2023

May 09, 2023

BUY
$3.74 - $7.46 $5.27 Million - $10.5 Million
1,408,697 New
1,408,697 $5.42 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $251M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Gmt Capital Corp Portfolio

Follow Gmt Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Gmt Capital Corp with notifications on news.